Key result
Transcutaneous auricular vagus nerve stimulation trial evaluates weight loss and gut-brain modulation in obesity.
Why the study?
The microbiota-gut-brain axis plays a key role in obesity pathogenesis, but the efficacy and mechanisms of transcutaneous auricular vagus nerve stimulation for weight reduction remain to be evaluated.
Population
74 patients with obesity
Comparison
taVNS vs sham taVNS
Design
Single-center randomized controlled trial protocol
Follow-up
12 weeks
Authors
Loading...
RCT (n=74)
Double-blind
1:1
No
Chen et al. (2025) conducted an RCT in Obesity (n=74). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Sham taVNS was evaluated on Percentage change in body weight from baseline to Week 12. Transcutaneous auricular vagus nerve stimulation will be evaluated for its efficacy in reducing body weight and modulating the microbiota-gut-brain axis in a 12-week randomized controlled trial of 74 patients with obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: